SaaS AI Platform for Trial Optimization

Asking PriceNot Disclosed

Cash Flow

EBITDANot Disclosed

Gross Revenue$10,677

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

listing imageSave

SaaS AI Platform for Trial Optimization


Asking PriceNot Disclosed

Cash Flow

EBITDANot Disclosed

Gross Revenue$10,677

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed


Seller Financing Available
Business Description
SaaS AI Platform for Trial Optimization
Our client has built a revolutionary Predictive Digital Twin platform transforming the clinical trial industry through AI-driven prognostic modeling. Founded by a Harvard-trained physician-scientist and robotics engineer, our client addresses the multibillion-dollar problem of patient recruitment and retention failures in pharmaceutical trials.

Using Federated Learning and a proprietary Self-Correcting Transformer (SCT) engine, our client integrates real-time clinical, molecular, and biosensor data to predict Enrollment Quality, Adherence Probability, and Therapeutic Response for each participant. This ensures the right patient is matched with the right trial — accelerating development timelines and reducing costs for sponsors.

NDA required to receive comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
About the Business
Years in Operation
1
Facilities & Assets
Home based business, portable.
Market Outlook / Competition
None have this revolutionary technology.
Opportunities for Growth
The company employs a Hybrid SaaS revenue model with recurring clinical site subscriptions and enterprise success fees from large pharmaceutical partners. The company is on the cusp of rapid growth but cannot do so on its own balance sheet presently to service customers already wanting to do business with the Company. 2026 will be $.3M, year 3 is projected to be > $10M, year 5 is projected to be > $50M in revenue.
With secured clinical partnerships and technical collaborations with AI and data science experts, our client is positioned for exponential sc
About the Sale
Seller Motivation
Find a growth partner to finalize MVP commercialization, and expand enterprise a
Transition Support
As needed.
Financing Options
TBD if structure and terms are acceptable.
Listing Info
ID
2448248
Listing Views

Contact Seller

By clicking the button, you agree to BizQuest's Terms of Use and Privacy Notice.

Business Listed by: Scott Cunningham Pronova Partners

Listing ID: 2448248 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.